Long‐acting glucagon‐like peptide‐1 receptor agonists have direct access to and effects on pro‐opiomelanocortin/cocaine‐ and amphetamine‐stimulated transcript neurons in the mouse hypothalamus

Liraglutide is a glucagon‐like peptide‐1 receptor (GLP‐1R) agonist marketed for the treatment of type 2 diabetes. Besides lowering blood glucose, liraglutide reduces bodyweight, and has recently also been approved for the obesity indication. Acutely, GLP‐1 markedly reduces gastric emptying, and this...

Descripción completa

Detalles Bibliográficos
Autores principales: Knudsen, Lotte Bjerre, Secher, Anna, Hecksher‐Sørensen, Jacob, Pyke, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Proceedings of INCRETIN 2015, A Symposium Celebrating the 45th Anniversary of the Discovery of GIP, 29–31 July 2015, Vancouver, Canada. This publication has been supported by: The Local Organizing Committee of INCRETIN 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854506/
https://www.ncbi.nlm.nih.gov/pubmed/27186357
http://dx.doi.org/10.1111/jdi.12463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854506/
https://www.ncbi.nlm.nih.gov/pubmed/27186357
http://dx.doi.org/10.1111/jdi.12463

Ejemplares similares